story of the week
Real-World Use Patterns, Effectiveness, and Tolerability of Sacituzumab Govitecan for the Second-Line and Later-Line Treatment of Metastatic TNBC in the US
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States
Breast Cancer Res Treat 2024 Jun 21;[EPub Ahead of Print], K Kalinsky, L Spring, C Yam, MA Bhave, I Ntalla, C Lai, N Sjekloca, B Stwalley, M Stokes, A Taylor, R NandaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.